Monoferric for Prenatal Iron Deficiency

Phase 1

Recruiting

• Conditions: Obstetric Labor Complications

• Registration Number: NCT05763043
• Lead Sponsor: Oregon Health and Science University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-2-28
• Last Update Posted: 23 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Inclusion Criteria:<br><br> - Participants 18 years of age or older between 14 to 42 weeks gestation who are<br> deemed appropriate for IV iron by their treating provider as part of their standard<br> of care treatment.<br><br> - Iron deficiency anemia, defined as second or third trimester (14 weeks or more)<br> hemoglobin less than or equal to 10.5 g/dL or less than or equal to11 g/dL,<br> respectively, and ferritin less than 50 µg/L<br><br> - Experience intolerance to oral iron or are greater than 28 weeks gestation<br><br> - Willing to participate in the study<br><br>Exclusion Criteria:<br><br> - Known infectious, inflammatory, or malignant conditions that may confound iron<br> repletion and outcome analysis<br><br> - Prior IV iron intolerance or hypersensitivity reaction

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of participants who experienced a resolution of iron deficiency anemia